Canada, EU To Probe Novartis Diabetes Drug
European and Canadian heath regulators are investigating a Novartis AG diabetes drug and advising doctors to stop prescribing it in combination with two other types of drugs for the time being,...To view the full article, register now.
Already a subscriber? Click here to view full article